Namouni Fouad
Insider CIK 1815851 · BPMC President, R & D · APRE Director · VOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 56,549 | — | $0 | 56,549 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,400 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 65,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 31,956 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-07-17 | 2025-07-21 | 39,456 | — | $0 | 115,237 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 83,281 | — | $0 | 31,956 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-07 | 6,489 | $88.80 | $576.2K | 75,781 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2025-03-01 | 2025-03-04 | 26,400 | — | $0 | 26,400 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-03-01 | 2025-03-04 | 13,200 | — | $0 | 82,270 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-10-03 | 2024-10-04 | 3,633 | $89.32 | $324.5K | 69,070 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-04-30 | 2024-05-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-11 | 4,377 | $90.69 | $397.0K | 72,703 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-03-01 | 2024-03-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-03-01 | 2024-03-06 | 15,000 | — | $0 | 77,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-10-04 | 2023-10-05 | 3,769 | $48.06 | $181.1K | 62,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 1,885 | $45.72 | $86.2K | 65,912 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 63 | $44.36 | $2.8K | 65,849 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-03-01 | 2023-03-03 | 15,000 | — | $0 | 67,797 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-10-04 | 2022-10-05 | 3,477 | $67.30 | $234.0K | 52,797 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-07 | 2022-03-08 | 1,047 | $56.19 | $58.8K | 56,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-03-01 | 2022-03-03 | 15,000 | — | $0 | 57,321 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-10-05 | 2021-10-07 | 3,241 | $98.18 | $318.2K | 42,321 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 22,750 | — | $0 | 22,750 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-06-30 | 2021-07-01 | 4,610 | — | $0 | 4,610 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-03-01 | 2021-03-03 | 26,125 | — | $0 | 26,125 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-03-01 | 2021-03-03 | 13,062 | — | $0 | 45,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-10-01 | 2020-10-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-10-01 | 2020-10-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 7,000 | — | $0 | 7,000 | SEC↗ |